Top Markets
Coin of the day
Kadimastem Ltd Kadimastem Ltd

Kadimastem Ltd

KDST
Peringkat dalam Saham #41019
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
Harga Saham
$12.16
Terakhir disinkronkan: 2025-10-30
Kapitalisasi Pasar
$50.98K
Perubahan (1 hari)
-0.10%
Perubahan (1 tahun)
60.98%
Negara
IL
Perdagangan Kadimastem Ltd (KDST)

Kategori

Riwayat hasil dividen untuk Kadimastem Ltd (KDST)
Hasil dividen (TTM) dari Kadimastem Ltd (simbol saham: KDST) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Kadimastem Ltd (KDST) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing